Medication therapy management (MTM): an innovative approach to improve medication adherence in diabetics
-
Athira Bindu Murali
,
Belsy Boban
Abstract
Background:
Medication therapy management (MTM) is a pharmacist-led professional service, one of the main aims of which is to improve patient medication adherence. Ensuring adequate adherence to the prescribed therapeutic regimen is one of the major challenges in attaining the desired therapeutic goals in diabetics. The objective of this study was to implement MTM in diabetic patients and to identify its effectiveness in improving patient medication adherence.
Methods:
A prospective interventional study was carried out within a 1-year period in KIMS-Al-Shifa Hospital, which is a tertiary care referral hospital in Malabar region of Kerala, including inpatients with type 2 diabetes mellitus in the general medicine department of the hospital. The MTM programme was applied in selected patients, including personal medication record, medication-related action plan and detailed counselling. Adherence was measured using the Modified Morisky Medication Adherence Scale-4 both before and after the programme.
Results:
A total of 104 patients were included in the study. The adherence of patients to anti-diabetic therapy was very low, which showed significant improvement after applying intervention (p-value<0.05 in a paired t-test). Initially, only 37.5% had high adherence which was increased to 59.5% after intervention. Age and educational status were identified to have a significant impact on patient medication adherence (p-value<0.05 in a χ2-test).
Conclusions:
Medication adherence is a key component of self-management for patients with diabetes. A pharmacist-led MTM programme if appropriately designed and implemented will have a potential positive impact on medication adherence in diabetic patients.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Pinto S, Kumar J, Partha G, Bechtol R. Pharmacist-provided medication therapy management (MTM) program impacts outcomes for employees with diabetes. Popul Health Manag 2014;17:21–7.10.1089/pop.2012.0124Search in Google Scholar PubMed
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53.10.2337/diacare.27.10.2569-aSearch in Google Scholar
3. Kutty VR, Soman CR, Joseph A, Kumar KV, Pisharody R. Random capillary blood sugar and coronary risk factors in a south Kerala population. J Cardiovasc Risk 2002;9:361–7.10.1177/174182670200900610Search in Google Scholar
4. Menon VU, Kumar KV, Gilchrist A, Sugathan TN, Sundaram KR, Nair V, et al. Prevalence of known and undetected diabetes and associated risk factors in central Kerala–ADEPS. Diabetes Res Clin Pract 2006;74:289–94.10.1016/j.diabres.2006.03.025Search in Google Scholar PubMed
5. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003.Search in Google Scholar
6. Delamater AM. Improving patient adherence. Clin Diabetes 2006;24:71–7.10.2337/diaclin.24.2.71Search in Google Scholar
7. Brummel A, Soliman A, Carlson A, de Oliveira D. Optimal diabetes care outcomes following face-to-face medication therapy management services. Popul Health Manag 2013;16:28–34.10.1089/pop.2012.0023Search in Google Scholar PubMed
8. Soliman A, Carlson A, MacLehose R, Brummel A, Schommer J. Patient characteristics predicting the frequency of medication therapy management visits for patients with diabetes. Clin Ther 2013;35:534–40.10.1016/j.clinthera.2013.02.026Search in Google Scholar PubMed
9. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 2010;16:185–95.10.18553/jmcp.2010.16.3.185Search in Google Scholar PubMed
10. Masica AL, Touchette DR, Dolor RJ, Schumock GT, Kliethermes MA, Rodgers PT, et al. Evaluation of a medication therapy management program in medicare beneficiaries at high risk of adverse drug events: study methods (vol. 4: technology and medication safety). Rockville, MD: Agency for Healthcare Research and Quality, 2008.Search in Google Scholar
11. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 2005;45:573–9.10.1331/1544345055001256Search in Google Scholar PubMed
12. Global Guidelines for Type 2 Diabetes. International Diabetes Federation, Clinical Guidelines Task Force, 2012.Search in Google Scholar
13. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence 2013;7:525–30.10.2147/PPA.S44698Search in Google Scholar PubMed PubMed Central
14. Bruce SP, Acheampong F, Kretchy I. Adherence to oral anti-diabetic drugs among patients attending a Ghanaian teaching hospital. Pharm Pract (Granada) 2015;13:533.10.18549/PharmPract.2015.01.533Search in Google Scholar
15. Serap T, Bayram Ş. Factors influencing adherence to diabetes medication in Turkey. Sch J Appl Med Sci 2015;3:602–6.Search in Google Scholar
16. Rwegerera GM. Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania – a cross-sectional study. Pan Afr Med J 2014;17:252.10.11604/pamj.2014.17.252.2972Search in Google Scholar PubMed PubMed Central
17. Sajith M, Pankaj M, Pawar A, Modi A, Sumariya R. Medication adherence to antidiabetic therapy in patients with type 2 diabetes mellitus. Int J Pharm Pharm Sci 2014;6:564–70.Search in Google Scholar
18. Arulmozhi S, Mahalakshmy T. Self-care and medication adherence among type 2 diabetics in Puducherry, Southern India: a hospital based study. J Clin Diagn Res 2014;8:1–3.Search in Google Scholar
19. Shams ME, Barakat EA. Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharm J 2010;18:225–32.10.1016/j.jsps.2010.07.004Search in Google Scholar PubMed PubMed Central
20. Williams JL, Walker RJ, Smalls BL, Campbell JA, Egede LE. Effective interventions to improve medication adherence in type 2 diabetes: a systematic review. Diabetes Manag (Lond) 2014;4:29–48.10.2217/dmt.13.62Search in Google Scholar PubMed PubMed Central
21. Butt M, Mhd Ali A, Bakry M, Mustafa N. Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life: a randomised controlled study. Saudi Pharm J 2016;24:40–8.10.1016/j.jsps.2015.02.023Search in Google Scholar PubMed PubMed Central
©2016 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Pharmacogenomics in pain treatment
- Original Articles
- Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH −1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence
- Medication therapy management (MTM): an innovative approach to improve medication adherence in diabetics
- Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?
- Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease
- The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation
Articles in the same Issue
- Frontmatter
- Review
- Pharmacogenomics in pain treatment
- Original Articles
- Association study of DRD2 A2/A1, DRD3 Ser9Gly, DβH −1021C>T, OPRM1 A118G and GRIK1 rs2832407C>A polymorphisms with alcohol dependence
- Medication therapy management (MTM): an innovative approach to improve medication adherence in diabetics
- Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?
- Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver disease
- The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation
